Method of preparing bio-identical hormones

• US 7,563,565 B1
• Filed: 01/28/2008
• Issued: 07/21/2009
• Est. Priority Date: 09/18/2002
• Status: Expired due to Fees

• Current Assignee: Susan Matsuo
• Original Assignee: Susan Matsuo
• Inventors: Matsuo, Susan, Barr, Teresa Leigh
• Primary Examiner(s): Lilling; Herbert J.
• Application Number:
  US12/020,670
• Time in Patent Office: 540 Days
• Field of Search: None
• US Class Current: 435/3
• CPC Class Codes: A61K 2300/00 Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
• CPC Class Codes: A61K 31/522 having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
• CPC Class Codes: A61K 31/56 Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
• CPC Class Codes: A61K 31/568 substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
• CPC Class Codes: Y10T 436/10 Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing

Abstract

The embodied composition is a dose of bio-identical hormones in a solvent with a vasodilator, a hormone modulator, and a carrier for balancing and maintaining Cortisol level in a human. The dose comprises progesterone ranging from about 0.005 wt % to about 41 wt %; pregnenolone ranging from about 0.005 wt % to about 41 wt %; ethoxydiglycol ranging from about 0.005 wt % to about 10 wt %; pentoxifylline ranging from about 0.005 wt % to about 10 wt %; ginseng ranging from about 0.005 wt % to about 41 wt %, and carrier q.s. Embodied herein is a method for balancing and maintaining Cortisol levels in humans by identifying the hormonal needs for a human, testing to ascertain the baseline hormone levels, inserting the values of baseline hormone level for each hormone into a hormone tree, balancing the hormones to a normal level, adjusting the levels for symptoms and sex type, and forming a resultant composition.

Claims

1. A method of preparing a dose of bio-identical hormones in a solvent with a vasodilator, a hormone modulator, and a carrier for balancing and maintaining cortisol levels in a human, comprising the steps of:

a. identifying the hormone needs for the human;

b. testing the human to ascertain a baseline hormone levels of each hormone in the human;

c. inserting the baseline hormone level of each hormone into a hormone tree;

d. balancing the hormone levels in a ratio that relates to a normal relationship of the hormones in the human;

thereby creating a balanced hormone value;

e. modifying the balanced hormone value to account for a symptom and a sex type of the human, thereby creating a symptom and gender accommodated value; and

f. recommending the dose based upon the symptom and gender accommodated value.

2. The method of claim 1, wherein the hormones are selected from the group consisting of:

androstenediol, andestrenedione, dehydroepiandrosterone, testosterone, estradiol, progesterone, estriol, pregnenlonone, estrogen, estrone, aldosterone, and combinations thereof.

3. The method of claim 1, wherein the symptoms are selected from the group consisting of:

infertility, hair loss, weight gain, depression, anxiety, panic attacks, insomnia, prostate issues, sexual enjoyment problems, acne, excessive hair growth, irritability, belligerence, libido, sneeze incontinence, cough incontinence, laugh incontinence, irregular menstrual cycles, libido, poor stress management, mood swings, hot flashes, and combinations thereof.

4. The method of claim 1, wherein the dose further comprises ginseng and a viscosity reducing agent.

5. The method of claim 1, wherein the step of testing the human to ascertain the baseline of baseline hormone levels for each hormone is done using a blood test or a saliva test, and wherein each hormone comprises DHEA, androstenedione, testosterone and androstenediol.

6. The method of claim 5, wherein the step of balancing the hormones in the ratio is balancing the ratio of DHEA with androstenediol and balancing the ratio of testosterone and androstenediol.

7. The method of claim 1, wherein the hormone tree comprises

a. a ratio of pregnenolone to progesterone of 40 mg/dl to <

1.5 ng/ml;

b. a ratio of progesterone to corticosterone and aldosterone of <

1.5 ng/ml;

c. a ratio of progesterone to Cortisol of <

1.5 ng/ml to 6-23 mcg/dl;

d. a ratio of pregnenolone to DHEA of 35-430 ug/dl to 0.7-3.1 ng/dl;

e. a ratio of DHEA to androstenedione of to 35-430 ug/dl to 0.7-3.1 ng/ml;

f. a ratio of androstenedione to testosterone of 0.7-3.1 to 6-86 ng/dl;

g. a ratio of estrone to estriol of 25-75 pg/ml to <

1.2;

h. a ratio of androstenedione to testosterone 0.7-3.1 ng/ml to 6-86 ng/dl;

i. a ratio of testosterone to estradiol of 6-86 ng/dl to 25-75 pg/ml; and

j. a ratio of testosterone to estriol of 6-86 ng/dl to <

1.2.